Ascendis Pharma A (ASND) Intangibles (2019 - 2025)

Ascendis Pharma A has reported Intangibles for 7 years, with the latest figure at $4.3 million in Q1 2026.

• Quarterly Intangibles rose 5.04% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.3 million (up 5.04% YoY) and the FY2025 annual result came in at $4.3 million, changed 0.33% from the prior year.
• Intangibles was little changed at $4.3 million in Q1 2026 per ASND's latest filing, from $4.3 million in the prior quarter.
• Over five years, Intangibles peaked at $6.2 million in Q4 2023 and troughed at $4.1 million in Q1 2025.
• A 5-year average of $4.7 million and a median of $4.4 million in 2025 frame the typical range for Intangibles.
• The sharpest annual moves came in 2023 and 2024: Intangibles rose 6.82% in 2023, then plunged 30.92% in 2024.
• Over 5 years, Intangibles stood at $5.8 million in 2022, then gained by 6.82% to $6.2 million in 2023, then plunged by 30.92% to $4.3 million in 2024, then grew by 0.33% to $4.3 million in 2025, then gained by 0.01% to $4.3 million in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $4.3 million, $4.3 million, and $4.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.